FDA approves gene therapy to treat a rare cancer

T cells

A gene therapy treatment called CAR-T immunotherapy has been approved for use in a rare type of leukemia. Immune cells called T cells (shown) are engineered to seek and destroy specific types of cancer.

Alex Ritter, Jennifer Lippincott Schwartz, Gillian Griffiths/NIH/Flickr (CC BY-NC 2.0)

This article is only available to Science News subscribers.

Subscribers, enter your e-mail address to access our archives.

Not a subscriber?

Science News is a nonprofit.

Support us by subscribing now.

More Stories from Science News on Health & Medicine

From the Nature Index

Paid Content